what is better semaglutide or tirzepatide vs. Semaglutide: Which for Weight loss? Tirzepatide vs Semaglutide: 2026 Clinical

Although these drugs can improve health and prevent some future medical costs, their high prices and need for long-term use mean that they will not lower overall group health plan sponsor medical costs

HLCP-2)

Overview GLP-1/GIP Dual Incretin Receptor Agonist is a research-grade dual-pathway incretin peptide supplied in lyophilized vial format for controlled laboratory use

The higher 2.4 milligram dose, Wegovy, is approved and prescribed for long-term weight management

Some large employers may opt into more generous plans that include coverage for weight loss medications, while others stick to a more basic, cost-effective formulary that excludes them entirely